BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22184265)

  • 21. Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
    Wu Q; Zhang J; Shi J; Ge M; Li X; Shao Y; Yao J; Zheng Y
    PLoS One; 2014; 9(11):e110787. PubMed ID: 25383872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age.
    Remes ST; Delezuch W; Pulkki K; Pekkanen J; Korppi M; Matinlauri IH
    Acta Paediatr; 2011 Sep; 100(9):e106-11. PubMed ID: 21401715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble CD30, dehydroepiandrosterone sulfate and dehydroepiandrosterone in atopic and non atopic children.
    Nogueira JM; Pinto PL; Loureiro V; Prates S; Gaspar A; Almeida MM; Pinto JE
    Allerg Immunol (Paris); 1998 Jan; 30(1):3-8. PubMed ID: 9503096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.
    Sengul S; Keven K; Gormez U; Kutlay S; Erturk S; Erbay B
    Transplantation; 2006 Apr; 81(8):1216-9. PubMed ID: 16641611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
    Halim MA; Al-Otaibi T; Al-Muzairai I; Mansour M; Tawab KA; Awadain WH; Balaha MA; Said T; Nair P; Nampoory MR
    Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
    Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
    J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.
    Szodoray P; Timar O; Veres K; Der H; Szomjak E; Lakos G; Aleksza M; Nakken B; Szegedi G; Soltesz P
    Scand J Immunol; 2006 Sep; 64(3):336-44. PubMed ID: 16918703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
    Altermann W; Schlaf G; Rothhoff A; Seliger B
    Nephrol Dial Transplant; 2007 Oct; 22(10):2795-9. PubMed ID: 17616534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation.
    Fields RC; Bharat A; Steward N; Aloush A; Meyers BF; Trulock EP; Chapman WC; Patterson GA; Mohanakumar T
    Transplantation; 2006 Dec; 82(12):1596-601. PubMed ID: 17198242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
    De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
    Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D; Wu GJ; Wu WZ; Yang SL; Chen JH; Wang H; Lin WH; Wang QH; Zeng ZX; Tan JM
    Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble CD30 in normal pregnancy, pre-eclampsia and recurrent pregnancy loss.
    Gharesi-Fard B; Jafarzadeh L; Zolghadri J; Haghbin H
    Iran J Immunol; 2012 Dec; 9(4):234-40. PubMed ID: 23268289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection.
    Vinante F; Krampera M; Morosato L; Rigo A; Romagnani S; Pizzolo G
    Haematologica; 1999 Aug; 84(8):683-9. PubMed ID: 10457402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation.
    Frisaldi E; Conca R; Magistroni P; Fasano ME; Mazzola G; Patanè F; Zingarelli E; Dall'omo AM; Brusco A; Amoroso A
    Transplantation; 2006 Apr; 81(8):1153-6. PubMed ID: 16641601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
    Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML
    Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATG induction therapy: long-term effects on Th1 but not on Th2 responses.
    Weimer R; Staak A; Süsal C; Streller S; Yildiz S; Pelzl S; Renner F; Dietrich H; Daniel V; Rainer L; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
    Transpl Int; 2005 Feb; 18(2):226-36. PubMed ID: 15691277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
    Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.